$7.41
+0.10 (+1.37%)
Open$7.33
Previous Close$7.31
Day High$7.56
Day Low$7.16
52W High$12.37
52W Low$2.52
Volume—
Avg Volume107.6K
Market Cap51.97M
P/E Ratio—
EPS$-1.77
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+161.9% upside
Current
$7.41
$7.41
Target
$19.41
$19.41
$13.09
$19.41 avg
$19.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.64M | 1.67M | 22.16M |
| Net Income | -12,843,699 | -7,310,478 | 3.56M |
| Profit Margin | -487.1% | -462.7% | 16.1% |
| EBITDA | -13,754,512 | -8,263,841 | 4.85M |
| Free Cash Flow | — | — | 3.49M |
| Rev Growth | +58.1% | +58.1% | +9.7% |
| Debt/Equity | — | — | 0.13 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |